Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/12/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/11/16 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 05/11/16 | 8-K | Current report filing |
|
35 | |
| 04/13/16 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
74 | |
| 04/13/16 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
163 | |
| 04/13/16 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
160 |
